Francis P. Grillo
Chief Executive Officer
Mr. Grillo joined MRI Interventions as President in October 2014 and became Chief Executive Officer in January 2015. Prior to joining MRI Interventions, Mr. Grillo served as Vice President, Marketing and New Business Development of Intuitive Surgical, Inc., a publicly-traded medical technology company, from August 2008. Before joining Intuitive Surgical, Mr. Grillo worked for Kyphon Inc. from February 2006 to June 2008, most recently as Vice President, Marketing and Business Development. Kyphon was a publicly-traded medical technology company prior to its acquisition by Medtronic, Inc. in November 2007. Prior to Kyphon, from September 1996 to January 2006, Mr. Grillo held various positions at Boston Scientific Corporation, most recently as Vice President, Marketing, Women’s Health, Urology/Gynecology Division. Mr. Grillo holds an MBA from J.L. Kellogg Graduate School of Management at Northwestern University and a B.S. degree in Chemical Engineering from Tufts University.
Peter G. Piferi
Chief Operating Officer
Mr. Piferi joined us in December 2006 as our Chief Operating Officer. Mr. Piferi has 30 years of industry experience in the areas of product development, manufacturing, quality and regulatory. Initially beginning his career in the aerospace industry, Mr. Piferi currently has over 20 years of experience in the medical device industry. Mr. Piferi has extensive medical device experience in various product lines, both implantable and disposable, including stents, catheters, guide wires, implantable cardiac support devices and neurosurgical devices. Mr. Piferi has been responsible for the development and commercialization of well over a dozen unique product platforms and the formation of over half a dozen medical device facilities, both in the U.S. and Internationally. Prior to joining MRI Interventions, Mr. Piferi served as the Vice President, Endovascular Technologies at Edwards Lifesciences Corporation, Vice President of Operations at Kriton Medical Inc. (currently Heartware International), Vice President of Operations at Orbus Medical Technologies, Inc. (currently Orbus Neich) and as Director of Advanced Engineering at Cordis Corporation, a Johnson and Johnson company. Mr. Piferi has a Bachelors of Science Degree from Central Connecticut University and an MBA from Rensselear Polytechnic Institute. Mr. Piferi currently has 6 issued U.S. patents, 18 U.S. patent applications and has co-authored several clinical publications.
Harold A. Hurwitz
Chief Financial Officer
Mr. Hurwitz joined us in March 2015 as Vice President, Finance and was appointed Chief Financial Officer in May 2015. Prior to joining MRI Interventions, from February 2013 to January 2015, Mr. Hurwitz served as Chief Executive Officer and President of Pro-Dex, Inc., a publicly-traded contract engineering and manufacturing company serving the medical device, factory automation and scientific research markets. Mr. Hurwitz also held the positions of Chief Financial Officer, Treasurer and Secretary of Pro-Dex from October 2010, when he joined that company, to January 2015. Between March 2010 and September 2010, Mr. Hurwitz served as an independent consultant, providing service primarily to a molecular diagnostics company. From April 2008 to February 2010, Mr. Hurwitz served as Chief Financial Officer and Vice President of Interventional Spine, Inc., a venture-backed medical device company. Prior to joining Interventional Spine, Mr. Hurwitz served as Principal Consultant with McDermott & Bull, a retained executive search firm, from December 2005 to March 2008, where he led the life science and medical technology practice. Mr. Hurwitz served as an independent consultant from December 2004 to December 2005, with his primary client during that time being Micro Therapeutics, Inc., then a publicly-traded medical device company (subsequently acquired by ev3, Inc., and now a part of Medtronic plc). He was Chief Financial Officer of Micro Therapeutics, Inc. from December 1997 to December 2004. Earlier in his career, Mr. Hurwitz was a Partner with Coopers & Lybrand L.L.P. (now a part of PricewaterhouseCoopers LLP), where he was a Business Assurance Partner, Team Leader of its Orange County Medical Device Practice and an SEC Review Partner. Mr. Hurwitz holds a B.A. in Economics from the University of California, Los Angeles. Mr. Hurwitz served as a director of Pro-Dex, Inc. from May 2013 to January 2015.
Vice President, Sales and Marketing
Ms. Maners joined us in December 2014 as Vice President, Marketing. Ms. Maners possesses more than two decades of global medical device experience focused on the marketing, acquisition, and licensing of medical device technologies. Prior to joining MRI Interventions, Ms. Maners served as Vice President, Emerging Technologies with CSA Medical, where she managed commercial marketing for the company’s products, led market development efforts for the company’s emerging applications in new market and disease segments and developed internal and external product training programs. Prior to her time with CSA Medical, Ms. Maners served for over 14 years in various roles at Boston Scientific Corporation, most recently as Vice President, Strategy and Business Development. During that time, she developed and executed acquisition strategies in the Neuromodulation and Electrophysiology markets, managed and built technology and venture capital business relationships to assemble a portfolio of investment options for supported divisions and served as a delegate Board member/observer for Boston Scientific investments, including Cyberonics, Northstar Neuroscience, Neuropace, Intelect Medical, IntraPace, Quallion and MRI Interventions. Ms. Maners is a graduate of the University of Southern California’s Marshall School of Business.
Vice President, Operations
Mr. Yelley joined MRI Interventions in January 2012 as Vice President, Operations. He has over 30 years of medical device experience in all areas of the business, including operations, manufacturing, engineering, quality and field support. Mr. Yelley possesses varied experiences in implantables, including stents and neuro coils, balloon catheters, neurovascular catheters and guidewires. Prior to joining the company, he served as Director of Operations/Engineering for ROX Medical, Director of Engineering for ev3/Covidien, Vice President of Operations at IntraLuminal Therapeutics and Vice President of Operations at Intravascular Research Limited. Mr. Yelley began his career with Medrad, then spent 12 years with ACS/Guidant in the engineering and operations area. He also possesses international experience, having spent three years in Europe during his tenure with Intravascular Research Limited. Mr. Yelley holds a BS degree in Chemical Engineering from Carnegie Mellon University and a MS degree in Manufacturing Management from Kettering University.